Skip to main content
. 2018 May 4;29(5):e69. doi: 10.3802/jgo.2018.29.e69

Table 1. Patient demographics.

Characteristic Value (n=21,537)
Age (yr) 56 (IQR 20)
<40 2,337 (10.9)
40–49 4,490 (20.8)
50–59 6,085 (28.3)
60–69 4,299 (20.0)
≥70 4,326 (20.1)
Race
White 16,044 (74.5)
Black 1,087 (5.0)
Hispanic 2,115 (9.8)
Asian 1,939 (9.0)
Others 352 (1.6)
Year
Before 1990 735 (3.4)
1990–1999 5,050 (23.4)
2000–2009 10,834 (50.3)
2010 or later 4,918 (22.8)
Registry
West 11,679 (54.2)
Central 4,391 (20.4)
East 5,467 (25.4)
Marital status
Single 4,296 (19.9)
Others 16,485 (76.5)
Unknown 756 (3.5)
Cancer stage
I 15,714 (73.0)
II 5,823 (27.0)
Histology type
Serous 7,466 (34.7)
Endometrioid 3,102 (14.4)
Clear cell 6,903 (32.1)
Mucinous 4,066 (18.9)
Grade
1 4,532 (21.0)
2 5,667 (26.3)
3 6,589 (30.6)
Unknown 4,749 (22.1)
Tumor size (cm)
≤10 7,684 (35.7)
>10 7,206 (33.5)
Unknown 6,647 (30.9)
No. of lymph nodes 11 (IQR 14)*
0 8,422 (39.1)
1–5 3,441 (16.0)
6–10 2,852 (13.2)
11–15 2,189 (10.2)
16–20 1,678 (7.8)
21–25 1,074 (5.0)
26–30 735 (3.4)
31–35 465 (2.2)
35–40 271 (1.3)
>40 412 (1.9)

Number (%) or median (IQR) is shown.

IQR, interquartile range.

*Median of removed lymph node among resected cases.